Text Size

Hold Parameters on Likely Cardiovascular Depressant Medications (HOLD)

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Hackensack University Medical Center
ClinicalTrials.gov Identifier:
NCT00527709
First received: September 7, 2007
Last updated: May 14, 2013
Last verified: May 2013
History of Changes
  Purpose

This pilot study is being pursued to observe whether certain medications are given to patients within a timeframe where their being given could play a part in a critical event in the management of the patient.

There are general rules about when it would be appropriate for these types of medications not to be given. However, it is not current standard practice for the criteria to be put in place without the expressed wishes of the ordering physician or their agent.

Research Question:

Can the administration of cardio-depressant medications be documented as a significant risk factor for hypotensive or bradycardic events?


Condition
Asystole
Bradycardia
Hypotension

Study Type: Observational
Study Design: Time Perspective: Retrospective

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Hackensack University Medical Center:

Study Start Date: August 2006
Estimated Primary Completion Date: August 2006 (Final data collection date for primary outcome measure)
  Eligibility

Genders Eligible for Study:   Both
Criteria

Inclusion Criteria:

  • Serial evaluation of the first 50 documented events of Code Blue or call to Rapid Response Team involving hypotension, bradycardia or asystole in the adult inpatient population events beginning January 1, 2006.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00527709

Locations
United States, New Jersey
Hackensack University Medical Center
Hackensack, New Jersey, United States, 07601
Sponsors and Collaborators
Hackensack University Medical Center
Investigators
Principal Investigator: Amit Tailor, MD, MBA Hackensack University Medical Center
  More Information

No publications provided

Responsible Party: Hackensack University Medical Center
ClinicalTrials.gov Identifier: NCT00527709     History of Changes
Other Study ID Numbers: 06.01.025
Study First Received: September 7, 2007
Last Updated: May 14, 2013
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Heart Arrest
Hypotension
Bradycardia
Heart Diseases
 Cardiovascular Diseases
Vascular Diseases
Arrhythmias, Cardiac
Pathologic Processes

ClinicalTrials.gov processed this record on May 21, 2013